BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8692006)

  • 1. Trypsin-like protease activity of Porphyromonas gingivalis as a potential virulence factor in a murine lesion model.
    Kesavalu L; Holt SC; Ebersole JL
    Microb Pathog; 1996 Jan; 20(1):1-10. PubMed ID: 8692006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of RgpA, RgpB, and Kgp proteinases in virulence of Porphyromonas gingivalis W50 in a murine lesion model.
    O'Brien-Simpson NM; Paolini RA; Hoffmann B; Slakeski N; Dashper SG; Reynolds EC
    Infect Immun; 2001 Dec; 69(12):7527-34. PubMed ID: 11705929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of cultivable Porphyromonas gingivalis with trypsin-like protease enzyme activity and serum antibodies in chronic adult periodontitis.
    Smith AJ; Wade WG; Greenman J; Addy M
    Oral Dis; 1995 Jun; 1(2):70-6. PubMed ID: 7553388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virulence of a polymicrobic complex, Treponema denticola and Porphyromonas gingivalis, in a murine model.
    Kesavalu L; Holt SC; Ebersole JL
    Oral Microbiol Immunol; 1998 Dec; 13(6):373-7. PubMed ID: 9872114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro environmental regulation of Porphyromonas gingivalis growth and virulence.
    Kesavalu L; Holt SC; Ebersole JL
    Oral Microbiol Immunol; 2003 Aug; 18(4):226-33. PubMed ID: 12823798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rag locus of Porphyromonas gingivalis contributes to virulence in a murine model of soft tissue destruction.
    Shi X; Hanley SA; Faray-Kele MC; Fawell SC; Aduse-Opoku J; Whiley RA; Curtis MA; Hall LM
    Infect Immun; 2007 Apr; 75(4):2071-4. PubMed ID: 17283109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed infection with Porphyromonas gingivalis and Fusobacterium nucleatum in a murine lesion model: potential synergistic effects on virulence.
    Feuille F; Ebersole JL; Kesavalu L; Stepfen MJ; Holt SC
    Infect Immun; 1996 Jun; 64(6):2094-100. PubMed ID: 8675312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LuxS-dependent quorum sensing in Porphyromonas gingivalis modulates protease and haemagglutinin activities but is not essential for virulence.
    Burgess NA; Kirke DF; Williams P; Winzer K; Hardie KR; Meyers NL; Aduse-Opoku J; Curtis MA; Cámara M
    Microbiology (Reading); 2002 Mar; 148(Pt 3):763-772. PubMed ID: 11882711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porphyromonas gingivalis hydrogen sulfide enhances methyl mercaptan-induced pathogenicity in mouse abscess formation.
    Nakamura S; Shioya K; Hiraoka BY; Suzuki N; Hoshino T; Fujiwara T; Yoshinari N; Ansai T; Yoshida A
    Microbiology (Reading); 2018 Apr; 164(4):529-539. PubMed ID: 29488863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear targeting of Porphyromonas gingivalis W50 protease in epithelial cells.
    Scragg MA; Alsam A; Rangarajan M; Slaney JM; Shepherd P; Williams DM; Curtis MA
    Infect Immun; 2002 Oct; 70(10):5740-50. PubMed ID: 12228304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological studies on virulence of dipeptidyl aminopeptidase IV (DPPIV) of Porphyromonas gingivalis in a mouse abscess model: use of a DPPIV-deficient mutant.
    Yagishita H; Kumagai Y; Konishi K; Takahashi Y; Aoba T; Yoshikawa M
    Infect Immun; 2001 Nov; 69(11):7159-61. PubMed ID: 11598093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental model for Porphyromonas gingivalis infection in animals.
    Eke PI; Rotimi VO; Laughon BE
    Afr J Med Med Sci; 1996 Mar; 25(1):31-9. PubMed ID: 9110052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of RagA and RagB in Porphyromonas gingivalis: study using gene-deletion mutants.
    Nagano K; Murakami Y; Nishikawa K; Sakakibara J; Shimozato K; Yoshimura F
    J Med Microbiol; 2007 Nov; 56(Pt 11):1536-1548. PubMed ID: 17965357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyromonas gingivalis virulence in a murine lesion model: effects of immune alterations.
    Kesavalu L; Holt SC; Ebersole JL
    Microb Pathog; 1997 Dec; 23(6):317-26. PubMed ID: 9441858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and testing of Porphyromonas gingivalis virulence genes with a pPGIVET system.
    Wu Y; Lee SW; Hillman JD; Progulske-Fox A
    Infect Immun; 2002 Feb; 70(2):928-37. PubMed ID: 11796628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyromonas gingivalis virulence in mice: induction of immunity to bacterial components.
    Kesavalu L; Ebersole JL; Machen RL; Holt SC
    Infect Immun; 1992 Apr; 60(4):1455-64. PubMed ID: 1312516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogenic virulence and related factors among clinical isolates of Porphyromonas gingivalis with type II fimbriae.
    Inaba H; Nakano K; Kato T; Nomura R; Kawai S; Kuboniwa M; Ishihara K; Ooshima T; Amano A
    Oral Microbiol Immunol; 2008 Feb; 23(1):29-35. PubMed ID: 18173795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteases of Porphyromonas gingivalis: what don't they do?
    Kuramitsu HK
    Oral Microbiol Immunol; 1998 Oct; 13(5):263-70. PubMed ID: 9807117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression and modification of proteases from an avirulent mutant of Porphyromonas gingivalis W50 (W50/BE1).
    Collinson LM; Rangarajan M; Curtis MA
    Microbiology (Reading); 1998 Sep; 144 ( Pt 9)():2487-2496. PubMed ID: 9782496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genes Contributing to
    Miller DP; Hutcherson JA; Wang Y; Nowakowska ZM; Potempa J; Yoder-Himes DR; Scott DA; Whiteley M; Lamont RJ
    Front Cell Infect Microbiol; 2017; 7():378. PubMed ID: 28900609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.